Keyphrases
Endometrial Cancer
90%
Extraperitoneal
20%
Uterine Aspirate
20%
Early Endometrial Cancer
16%
Endometrial Carcinoma
16%
Ovarian Cancer
15%
Prognostic Biomarker
15%
Para-aortic Lymphadenectomy
13%
Molecular Profile
13%
Tumor
12%
ETV5
12%
Technetium-99m
11%
Transcription Factor
11%
Clinical Management
11%
Indocyanine Green
11%
Lymph Node Metastasis
10%
Sentinel Lymph Node Mapping
10%
Locally Advanced Cervical Cancer
9%
Survival Outcomes
9%
Clinical Outcomes
8%
Sentinel Lymph Node Biopsy
8%
Overall Survival
7%
Endometrioid Endometrial Cancer
7%
Liquid Biopsy
7%
Ovarian Cancer Cells
7%
Clinical Presentation
7%
Presentation Management
7%
Systematic Meta-analysis
7%
Meta-analysis
7%
Recurrence Pattern
7%
Surgical Complications
7%
Molecular Classification
7%
Cancer Patients
7%
Metastasis
7%
Gynecologic Malignancies
6%
Disease-free Survival
6%
Patient-derived Xenograft
6%
Aortic Lymphadenectomy
6%
Hysteroscopy
5%
Lymphovascular Invasion
5%
Prognostic Factors
5%
Surgical Treatment
5%
Gene Expression
5%
Surgical Staging
5%
Signaling Pathway
5%
Oncological Outcomes
5%
Blood Loss
5%
Cancer Diagnosis
5%
Endometrial Adenocarcinoma
5%
Overexpression
5%
Medicine and Dentistry
Uterine Cancer
100%
Recurrent Disease
24%
Diseases
21%
Endometrium Carcinoma
21%
Retroperitoneal Lymph Node Dissection
20%
Ovarian Cancer
20%
Biological Marker
19%
Neoplasm
19%
Metastatic Carcinoma
16%
Aspiration
16%
Cervical Cancer
14%
Technetium-99
11%
Transcription Factors
11%
Systematic Review
11%
Indocyanine Green
11%
Sentinel Lymph Node
11%
Cancer Cell
10%
Postoperative Complication
10%
Lymph Node
9%
Lymph Duct
9%
Bleeding
8%
Sentinel Lymph Node Biopsy
8%
Cancer
8%
Surgery
7%
Operation Duration
7%
Human Immunodeficiency Virus
7%
Liquid Biopsy
7%
Meta-Analysis
7%
Prognostic Factor
6%
Signal Transduction
6%
Protein P53
6%
Xenograft
6%
Laparoscopic Surgery
6%
Overall Survival
6%
Gynecological Oncology
5%
Disease Free Survival
5%
Proteomics
5%
Gene Expression
5%
Paraaortic Lymph Node
5%
